Rhumbline Advisers increased its holdings in American Renal Associates Holdings, Inc (NYSE:ARA) by 2.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,383 shares of the company’s stock after purchasing an additional 354 shares during the period. Rhumbline Advisers’ holdings in American Renal Associates Holdings were worth $248,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Schwab Charles Investment Management Inc. boosted its stake in shares of American Renal Associates Holdings by 0.7% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 39,132 shares of the company’s stock valued at $726,000 after purchasing an additional 285 shares in the last quarter. Taylor Cottrill Erickson & Associates Inc. purchased a new stake in shares of American Renal Associates Holdings in the 2nd quarter valued at $12,137,000. Strs Ohio boosted its stake in shares of American Renal Associates Holdings by 12.6% in the 2nd quarter. Strs Ohio now owns 33,000 shares of the company’s stock valued at $612,000 after purchasing an additional 3,700 shares in the last quarter. Acadian Asset Management LLC boosted its stake in shares of American Renal Associates Holdings by 46.7% in the 2nd quarter. Acadian Asset Management LLC now owns 51,102 shares of the company’s stock valued at $948,000 after purchasing an additional 16,271 shares in the last quarter. Finally, Van Berkom & Associates Inc. purchased a new stake in shares of American Renal Associates Holdings in the 2nd quarter valued at $6,886,000. 89.92% of the stock is owned by institutional investors.

American Renal Associates Holdings (NYSE:ARA) last posted its earnings results on Tuesday, August 8th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. American Renal Associates Holdings had a negative net margin of 1.54% and a positive return on equity of 18.25%. The firm had revenue of $185.99 million during the quarter, compared to analyst estimates of $188.23 million. The firm’s revenue for the quarter was up .2% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: This story was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/10/13/rhumbline-advisers-increases-stake-in-american-renal-associates-holdings-inc-ara.html.

Separately, Zacks Investment Research cut shares of American Renal Associates Holdings from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $22.33.

American Renal Associates Holdings Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Institutional Ownership by Quarter for American Renal Associates Holdings (NYSE:ARA)

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.